Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.49 | 0.49 | 0.00 |
Shares | 98.79 | 98.79 | 0.00 |
Bonds | 0.01 | 0.01 | 0.00 |
Convertible | 0.03 | 0.03 | 0.00 |
Preferred | 0.26 | 0.26 | 0.00 |
Other | 0.42 | 0.42 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.72 | 20.48 |
Price to Book | 5.13 | 4.65 |
Price to Sales | 2.42 | 2.71 |
Price to Cash Flow | 19.67 | 18.41 |
Dividend Yield | 1.13 | 1.04 |
5 Years Earnings Growth | 17.43 | 16.41 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.99 | 99.59 |
Basic Materials | 0.01 | 0.43 |
Number of long holdings: 110
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.92 | 748.01 | -0.25% | |
UnitedHealth | US91324P1021 | 6.72 | 590.87 | -1.11% | |
Novo Nordisk B | DK0062498333 | 5.33 | 750.9 | +4.03% | |
AstraZeneca | GB0009895292 | 4.00 | 10,474.0 | +4.09% | |
AbbVie | US00287Y1091 | 3.61 | 176.95 | +3.04% | |
Amgen | US0311621009 | 3.20 | 294.53 | +1.60% | |
Merck&Co | US58933Y1055 | 2.79 | 99.18 | -0.68% | |
Sanofi | FR0000120578 | 2.63 | 93.17 | +2.53% | |
Boston Scientific | US1011371077 | 2.46 | 90.00 | -1.64% | |
Novartis ADR | US66987V1098 | 2.34 | 104.28 | +0.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 17.13B | 28.08 | 9.04 | 14.22 | ||
Janus Balanced I | 11.58B | 13.44 | 3.91 | 8.66 | ||
Janus Enterprise I | 8.66B | 13.43 | 4.63 | 12.56 | ||
Janus Henderson Balanced Portfolio | 8.6B | 13.25 | 3.71 | 8.38 | ||
Janus Enterprise N | 6.89B | 13.52 | 4.73 | 12.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review